As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  3/4/19  Leung Sandra                      4          Officer²    1:7K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  3/4/19  Bancroft Charles A                4          Officer²    1:7K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
 2/28/19  Starboard Value LP                DFAN14A     2/28/19    2:3.7M Bristol-Myers Squibb Co.          Olshan Frome Wolosky LLP 
 2/28/19  Bristol-Myers Squibb Co.          425                    1:75K  Celgene Corp./DE                  Broadridge Fin’l So… Inc 
 2/28/19  Bristol-Myers Squibb Co.          425                    1:15K  Celgene Corp./DE                  Broadridge Fin’l So… Inc 

____________
¹	Filing/Form Types:  /A
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	425	Prospectus or Communication – Merger.
	DFAN14A	Definitive Additional Non-Management Proxy Soliciting Material — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.